BrainCool AB (publ) - inlösenperiod för BrainCools optioner, BRAIN TO 3, 2019 - 2022, 22 februari – 8 mars 2021
![BrainCool AB (publ) update of EU grant (BRAINCELL – combined TTM / thrombectomy treatment) - BrainCool BrainCool AB (publ) update of EU grant (BRAINCELL – combined TTM / thrombectomy treatment) - BrainCool](https://mb.cision.com/Public/11624/3443855/87e73299ca398895_800x800ar.png)
BrainCool AB (publ) update of EU grant (BRAINCELL – combined TTM / thrombectomy treatment) - BrainCool
![BrainCool Announces Statistically Significant Late-Breaking Clinical Data at ESMO Virtual Congress 2020 BrainCool Announces Statistically Significant Late-Breaking Clinical Data at ESMO Virtual Congress 2020](https://mma.prnewswire.com/media/1276594/COORAL_Logo.jpg)
BrainCool Announces Statistically Significant Late-Breaking Clinical Data at ESMO Virtual Congress 2020
![FDA Breakthrough Device Designation Awarded To BrainCool AB's Cooral System | Medical Product Outsourcing FDA Breakthrough Device Designation Awarded To BrainCool AB's Cooral System | Medical Product Outsourcing](https://images.rodpub.com/images/228/822_main.jpg)